- Home
- SF vs SNN Comparison
SF vs SNN Comparison
Compare SF & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SF | SNN |
|---|---|---|
| Founded | 1890 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 12.3B |
| IPO Year | 1994 | 2002 |
Fundamental Metrics
Financial Performance| Metric | SF | SNN |
|---|---|---|
| Price | $71.36 | $31.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 6 |
| Target Price | ★ $80.88 | $32.72 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 10-21-2026 | 08-04-2026 |
| Dividend Yield | 1.89% | ★ 2.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $6,347,533,000.00 | N/A |
| Revenue This Year | $7.50 | $4.70 |
| Revenue Next Year | $7.90 | $5.07 |
| P/E Ratio | ★ $17.24 | $64.97 |
| Revenue Growth | ★ 6.65 | N/A |
| 52 Week Low | $65.40 | $26.30 |
| 52 Week High | $134.74 | $37.09 |
Technical Indicators
Market Signals| Indicator | SF | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 60.45 |
| Support Level | $68.47 | $29.18 |
| Resistance Level | $74.68 | $31.32 |
| Average True Range (ATR) | 1.83 | 0.61 |
| MACD | 0.88 | 0.16 |
| Stochastic Oscillator | 63.35 | 51.87 |
Price Performance
Historical ComparisonAbout SF Stifel Financial Corporation
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a Saint Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from trading and investment banking.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.